Loading data...
Hanamaru Notebook Co., Ltd.
CEO
Takumi Yoshino
Empowering your company to operate a comprehensive end-of-life and inheritance planning platform under your own brand.
Recent News & PR
Summary
Message to Participants
Detailed Information
We provide a white-label inheritance end-of-life platform to organizations and companies. Currently, companies and organizations that want to implement comparison services related to inheritance end-of-life and disseminate information face barriers in building a network of local experts. Our system has over 1,000 registered experts, allowing for the customization of listed experts while utilizing them, and we are in a position to offer OEM services, with a track record of implementation in 95 organizations and companies.
Unfair Advantage & Strengths
N/A
Competitors
N/A
Company Profile
事業カテゴリ
SaaS / B2B Software, Healthcare / Biotech
本社所在地
null
設立日
2020/4/13
資本金
2,854万円
Employee Count
2
Industry Outlook & Trends for Hanamaru Notebook Co., Ltd.
Driven by aging populations and rising healthcare costs, the healthcare and biotech market where Hanamaru Notebook Co., Ltd. operates is growing globally. Telemedicine, digital health via wearables, AI-driven drug discovery, and gene therapy are advancing rapidly. The industry is shifting from treatment to prevention, increasing demand for highly personalized health solutions like those developed by Hanamaru Notebook Co., Ltd..
🔒
VPO Investor Pro Features
You are viewing a basic startup profile. Create a free account to access the dashboard. You can also upgrade to the "Investor Pro" plan to unlock full access to the following premium databases and features:
🎬
Elevator & Full Pitch Video
Watch full presentations with English/Japanese subtitles.
📊
AI Quick Report & Valuation
Get AI-driven assessment scores on market, product, and traction.
📅
Priority Challenges & Hiring
Access core corporate bottlenecks and current hiring plans.
📝
Full Transcripts
Read full pitch dialogue in both English and Japanese.
📈
Financials & Exit Strategy
Unlock IPO/M&A timelines and debt/equity plans.
👥
Advisors & Key Members
View internal team details and advisory board configurations.